run out creative Malfunction allergy peg simple Ours employment
Polyethylene glycol as marker for nitrofurazone allergy: 20 years of experience from Turkey - Özkaya - 2018 - Contact Dermatitis - Wiley Online Library
Positive skin test to pegylated drug in a patient with anaphylaxis to polyethylene glycol - ScienceDirect
Suspicions grow that nanoparticles in Pfizer's COVID-19 vaccine trigger rare allergic reactions | Science | AAAS
Advice to PCN LVS centres and GPs - for individuals with a previous allergic reaction having the Pfizer-BioNTech or AstraZeneca
Patient Case Summary With Triggering Agents and Associated PEG... | Download Scientific Diagram
Immediate allergic reactions by polyethylene glycol 4000: two cases - ScienceDirect
Optimizing investigation of suspected allergy to polyethylene glycols - ScienceDirect
Successful SARS-CoV-2 vaccine allergy risk-management: The experience of a large Italian University Hospital
Utility of skin testing in assessment of post-AZD1222 vaccine (AstraZeneca) allergic reactions: case series in Vietnam
The Polysorbate containing AstraZeneca COVID‐19 vaccine is tolerated by polyethylene glycol (PEG) allergic patients - Sellaturay - 2022 - Clinical & Experimental Allergy - Wiley Online Library
Positive reaction after handling PEG-4000. | Download Scientific Diagram
COVID-19 Vaccinations and Allergies FAQ | Allergy UK | National Charity
Immediate hypersensitivity to polyethylene glycols in unrelated products: when standardization in the nomenclature of the components of drugs, cosmetics, and food becomes necessary | Allergy, Asthma & Clinical Immunology | Full Text
Polyethylene glycol (PEG) is a cause of anaphylaxis to the Pfizer/BioNTech mRNA COVID‐19 vaccine - Pharma Excipients
Positive reaction after handling PEG-4000. | Download Scientific Diagram
Improving vaccine allergy tests | Faculty of Sciences, Engineering and Technology | University of Adelaide
Coroner urges action after KGH patient dies of rare PEG allergy | Northamptonshire Telegraph
New Insights on Cause of Rare Anaphylaxis Following COVID-19 Vaccination – Global Biodefense